CEPI partners with BioNet to expand variant-proof vaccine programme
The award is part of CEPI’s $200m programme to advance the development of broadly protective coronavirus vaccines. OSLO, Norway, 25 January 2022: CEPI, the Coalition for Epidemic Preparedness Innovations, today announced the latest award under its $200m programme, launched in March 2021, to advance the development of vaccines that provide broad protection against SARS-CoV-2 variants...